Oxycodone inventor is now marketing a drug to wean addicts off opioids

Richard Sackler, former chairman and president of Purdue Pharma, has patented a new drug to help wean addicts from opioids. The drug is a form of buprenorphine, a mild opioid that is used to ease withdrawal symptoms.

Richard Sackler, former chairman and president of Purdue Pharma, has patented a new drug to help wean addicts from opioids. The drug is a form of buprenorphine, a mild opioid that is used to ease withdrawal symptoms. However, some are expressing outrage that the Sacklers, whose family owns Purdue Pharma, may soon be profiting from the antidote to opioid addictions that they in essence also profited from. The patent states that the drug could be used both in drug replacement therapy as well as for pain management.